Company / FCF Margin
TriSalus Life Sciences, Inc. FCF Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-139.9%
FY2025
5-year range
-276.4% / -139.9%
FY2023-FY2025
Trend
+49.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -265.9% to -139.9% over the past 2 years.
Based on SEC 10-K filings.
-139.9% in FY2025.
Improved from -265.9% to -139.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 49.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.11 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -139.9% | +49.4% |
| FY2024 | -276.4% | -3.9% |
| FY2023 | -265.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026